Endodontic Microsurgery With the Use of L-PRF and an Occlusive Membrane: a Randomized Controlled Clinical Trial
- Conditions
- Periapical Periodontitis
- Interventions
- Procedure: EMSDevice: + occlusive membraneDevice: conebeam CT
- Registration Number
- NCT02528240
- Lead Sponsor
- Universitaire Ziekenhuizen KU Leuven
- Brief Summary
This study evaluates the effect of leucocyte and platelet rich fibrin (L-PRF) during endodontic microsurgery (EMS) on patient's post-operative comfort and periapical bone healing. Also the influence of an occlusive membrane barrier in EMS on the periapical bone healing will be studied. The trial design is an open randomized controlled clinical trial with a 2x2 factorial design. Half of the participants will receive EMS with L-PRF (experimental group), the other half without (control group). The control and experimental group will be divided in 2 subsequent groups: half of the participants will receive an occlusive membrane during EMS, the other half not.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 56
- Provision of Informed Consent
- Patients in need of an EMS
- EMS is the only option to cure the periapical lesion
- Unlikely to be able to comply with the study procedures, as judged by the investigator
- Orthograde endodontic (re)treatment is indicated
- Known or suspected current malignancy
- History of chemotherapy within 5 years prior to study
- History of radiation in the head and neck region
- History of other metabolic bone diseases
- History of bleeding disorders
- HIV disease
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- FACTORIAL
- Arm && Interventions
Group Intervention Description + L-PRF conebeam CT With leukocyte and platelet rich fibrin - L-PRF conebeam CT Without leukocyte and platelet rich fibrin + L-PRF EMS With leukocyte and platelet rich fibrin + L-PRF + occlusive membrane With leukocyte and platelet rich fibrin - L-PRF EMS Without leukocyte and platelet rich fibrin
- Primary Outcome Measures
Name Time Method Patient related outcomes 7 days Assessed with a Visual Analog Scale
- Secondary Outcome Measures
Name Time Method Patient related outcomes 7 days Assessed with a questionnaire
Trial Locations
- Locations (1)
UZ Leuven
🇧🇪Leuven, Belgium